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Radiation therapy is an important treatment modality for tumors in the central nervous 
system. However, ionizing radiation (IR) gives rise to long-term cognitive deficits in 
patients, such as intellectual and memory impairments and this is believed to be partly 
due to irradiation-damage on adult neurogenesis, birth of new neurons, in the dentate 
gyrus of the hippocampus in the brain. Studies on rodents have shown that voluntary 
running can restore adult hippocampal neurogenesis after IR. Further, one study have 
reported a potential link between exercise and adult neurogenesis through a PGC-
1a/FNDC5 pathway. Here, we examine if expression of the muscle exercise gene PGC-
1a contributes to beneficial effects on recovery after cranial IR in mouse using a 
transgenic mouse model that constitutively overexpress PGC-1a in skeletal muscle. 
Male animals were subjected to whole brain IR (4 Gy) at 4 months age. Animals were 
given daily intraperitoneal injections of BrdU (50 mg/kg) from day 3 to 8 post IR. For 
voluntary exercise, female animals were single housed in cages with free access to 
running wheels. After 5 days of acclimatization, half of the running wheels were 
unlocked and animals were given daily intraperitoneal injections of BrdU (50 mg/kg) 
for 3 consecutive days. Animals were euthanized 4 weeks after IR, or unlocking of 
running wheels, for immunohistochemical analysis. We did not find any changes in 
baseline or exercise-induced levels of neurogenesis, or difference in baseline or 
irradiation-reduced levels of neurogenesis. In summary, we conclude that forced 
muscular expression of PGC-1a does not have a beneficial effect on hippocampal 




muscle is by itself not sufficient to mimic exercise-induced recovery after IR.  
Key Words: Neurogenesis, hippocampus, PGC-1a, irradiation, voluntary exercise. 
INTRODUCTION 
 
The cellular and molecular mechanisms underlying exercise-induced changes in brain 
function are currently being characterized in rodent models. By understanding the 
cellular and molecular consequences of wheel running in the rodent brain, it may be 
possible to develop novel therapeutic interventions that mimic the positive effects of 
exercise. These potential pharmaceuticals will particularly be good for those who are 
unable to engage in vigorous physical activity (coma, spinal cord injury, etc) or in 
patient groups where the adherence rate for voluntary exercise programs are low and 
compliance would likely be far higher for an exercise pharmacomimetic, e.g children 
and elderly weak patients. Uncovering the molecular and cellular linkages between 
physical exercise and hippocampal neurogenesis is critical to advancements towards 
the creation of neuroprotective agents that can be administered to patients who risk 
long-term neurocognitive sequelae after radiation therapy and/or suffer from 
neurodegenerative diseases. This degree project in medicine have contributed to a 
bigger PhD project that studies the molecular mechanism behind the positive effects 
from exercise on adult neurogenesis in the brain hippocampus. The following 
paragraphs describes what neurogenesis is.  
Neurogenesis and regenerative medicine 
The central nervous system (CNS) was widely perceived as a structurally fixed, non-
cellular organ that is incapable of regeneration, until Altman's pioneering studies that 




granule cells in the postnatal rat hippocampus (1). Despite his findings, the non-
regenerative capability of the adult damaged brain still remained as an accepted 
scientific dogma for decades. However, accumulating evidence indicated that neurons 
and astrocytes can be generated from isolated cells of the adult mammalian CNS (2). 
This birth of neurons is the process by which neurons are generated from neural stem 
cells and progenitor cells in the postnatal brain, now termed adult neurogenesis. Later, 
Peter Eriksons’ 1998 study confirmed that new neurons are also generated in the 
hippocampus of adult humans (3). Adult neurogenesis takes place in at least two 
cytogenic niches, the subventricular zone of the lateral ventricles and the subgranular 
zone (SGZ) in the dentate gyrus (DG) of the hippocampus (4). On top of this, 
regenerative medicine has emerged as a new scientific field advancing stem cell therapy 
for treating brain disorders, with emphasis on either transplanting exogenous stem cells 
or amplifying endogenous stem cells via neurogenesis (5, 6). The later, is subject in this 
project paper.  
 
 
Figure 1: The hippocampus is located within the medial temporal lobe of the human 




Hippocampus: anatomy, function and neurogenesis 
The hippocampus, or the hippocampal formation, that holds the SGZ which is one of 
the two locations for adult neurogenesis in the brain, is a bilateral structure found within 
the medial temporal lobes of the human brain hemispheres (Fig 1). The hippocampal 
formation belongs to the limbic system and is considered to play a key role in the 
learning process, short-term memory and spatial navigation (8), but the precise nature 
of this role remains widely debated (8-11).  
The hippocampus consists of different anatomical parts (Fig 2). The SGZ is outlined 
by the border between the granular cell layer (GCL) and hilus. The SGZ contain stem 
cells and progenitor cells. They play a key role in maintaining hippocampal functions 
such as memory and learning. They are also considered to be of importance in the 
functional recovery after CNS injury due to their regenerative potential (12-15). The 
GCL, together with the SGZ defines the structure of the dentate gyrus (DG) of the 







Figure 2: Anatomical description of the different hippocampal layers in mice. The 
pyramidal layer (PL) is divided into three subareas (CA1‐ 3). The stratum lucidum 
(SL) is a separate area alongside the PL. The SGZ is outlined by the border between 
the GCL and hilus. Colors outline the areas: GCL (blue), molecular cell layer (MCL, 
magenta), Hilus (green), PL (white), CA1 (red), CA2 (orange), CA3 (yellow) and SL 
(black). Used and edited by permission from Lars Karlsson. 
 
Function of the Dentate gyrus 
 
One of the main objectives behind research within this field is to find means to 
ameliorate the pathological effects from for example neurodegenerative diseases and 
long-term neurocognitive sequelae after radiotherapy (RT). Examples of such 
neurocognitive sequelae are varied kinds of memory impairments. As stated above, the 
hippocampus play an important role in memory, but it’s still extensively researched 
about which and how the different anatomical parts of the hippocampus contribute to 
the memory function. In the scope of this degree project, the function of the DG is 
central as it is the site for adult neurogenesis, thereby most relevant to discuss. The 
most common theory of the function of the DG of the hippocampal formation is pattern 
separation of sensory information to the hippocampus. As events are experienced, 
cortical inputs from the enthorinal cortex reach the hippocampus via the perforant path, 
which projects to both DG and CA3 (16). It is believed that DG compresses and 
conjunctively encodes multimodal sensory and spatial representations about the 
environment and projects it further downstream in the hippocampus for processing, 
which results in minimal interference between overlapping spatial or contextual 
information. Both experimental lesion studies in rodents and neurocognitive testing and 
fMRI studies in humans supports this role of the DG (17, 18). However, because 
“pattern separation” is a feature of most brain circuits, some scientist argue it is better 




as ”binding” (20), but this difference in terminology is mostly semantic.  
 
Function of Adult Neurogenesis. 
Extensive research, using several different approaches, increasingly suggest that the 
role of the adult neurogenesis is highly complex and affects multiple aspects of 
learning, as opposed to having a clearly definable function (17). However, as the adult 
neurogenesis takes place in the dentate gyrus, it is believed to play a critical role in 
pattern separation. During the maturation process (see below) of the adult-born granular 
cells (GC), studies have shown that these immature neurons may be hyperexcitable, in 
comparison to more mature granular cells, suggesting that their functional contribution 
to DG function is different, from more mature GC in the DG network (21, 22). In short, 
the common theoretical framework for adult neurogenesis role in DG pattern 
separation, is that a continuous neurogenesis results in a combination of signals from 
the DG to the CA3 that consists of two separate populations;  
a) one population of broadly tuned GC that weakly encode most of the features of 
the environment, and  
b) one sparse population of sharply tuned GC that strongly encode only features 
that have been previously experienced.  
Together, they promote high memory resolution/pattern separation while at the same 
time keeping already formed memories distinct, and minimizing interference in 
downstream networks (19). This is consistent with some experimental studies, for 
example, when adult neurogenesis is blocked either by IR or by genetic ablation, 
discrimination is impaired leading to generalization and inability to distinguish 
context/object A from B. In contrast, when neurogenesis is stimulated by genetic 




Maturation process of new born granular cells in the adult hippocampus 
Because neurogenesis in the adult hippocampus is the process in which new cells are 
born to become neurons, naturally, this process consists of a couple of general, 
developmental phases (23) (Fig 3) which can be tracked and analyzed using different 
cell markers. The process begins with an expansion phase where radial glia-like stem 
cell with the capacity for self-renewal, start to multiply through cell division within the 
SGZ occurs (24, 25). Thereafter, there are at least two consecutive amplifying lineages 
of progenitor cells where immature cells with the ability to differentiate into neurons 
start to accumulate and migrate into the GCL (25). After the expansion phase comes 
the survival and elimination phase, where the early survival phase of the amplified stem 
cells begin with the exit from the cell cycle. The cells begin to extend their axons and 
dendrites towards the molecular layer perforant path-associated cells in MCL in order 
to receive their first synaptic input and progress into the postmitotic maturation phase. 
The main synaptic input to the new cells is GABAergic and drives the ongoing 
maturation until the glutamatergic input from the entorhinal cortex (adjacent to the CA1 
area of the PL) sets in (26). The majority of the cells fail to establish functional 
connections during this stage and are therefore eliminated through an apoptotic process. 
The glutamergic input drives the late survival phase that is a continuation of the 
maturation process for the neuronal cell and its dendritic spines. Once glutamergic 
synaptic connections have been made, the new neurons go through a phase of increased 
synaptic plasticity where the threshold for long-term potentiation is lowered. The total 
time for the neurogenetic process, when the differentiated cell becomes 
indistinguishable from old neuronal cells, is approximately 7 weeks (26, 27). Mature 
neurons express the postmitotic neuronal marker NeuN, the most widely used indicator 




for mitotic cells in studies of adult neurogenesis (29). BrdU is an analog to thymidine 
that can be administered systematically. BrdU is a false base that competes with 
endogenous thymidine during the synthesis phase of the cell cycle.  Ki-67 is also a 
mitotic marker that can be used as an alternative, endogenous marker for proliferation 
(30). The antibody Ki-67 identifies a cell cycle associated protein that appears to be 
essential for cell cycle progression, but the exact function of the protein is unknown. 
The Ki67 marker appears in cells during late G1, S, G2 and M phases, but not in cells 
in late G0- and early G1 phase. One study has shown that Ki67 immunohistochemistry 
yield higher number of proliferating cells compared to BrdU (30). In contrast to Ki67, 
or other endogenous markers of cell division, BrdU identifies cells dividing at the time 
of marker injection, not when the tissue specimen was fixated, in which the tissue is 
prepared with solutions to immobilize antigens while retaining cellular and subcellular 
structure. Thus, BrdU allows the labeling of a cohort of cells undergoing division at the 
known time when BrdU was applied. This allows researchers to use various study 
designs, where they can control the interval between the time-point of birth-marking by 
BrdU-injections/BrdU-incorporation and the collection of tissue and its analysis. This 
interval can be set to days, weeks or years, and gives the labeled cells sufficient time to 
differentiate and mature into neurons. It is this fundamental difference that is the basis 
for the identification of new neurons with the BrdU method. However, because the 
synthesis phase only comprises half or less of the entire cell cycle, the BrdU method 
will underestimate the true, absolute size of the proliferating cell population. These 





Figure 3: Overview of the adult neurogenesis in hippocampus. 
Radial glia-like stem cell (green) divides and immature progenitor cells (yellow) start 
their differentiation towards becoming neurons. The cell maturation continues by 
exiting the cell cycle and the cells (red) start to stretch out their dendritic trees 
towards the MCL to establish functional synaptic connections. The increasing 
synaptic input to the cells (violet) drives the maturation process to its final phases 
where the cell is considered a mature neuron. 
 
Physical activity and brain health 
 
The health benefits of regular exercise are well documented, with an abundance of 
evidence pointing to a decreased risk of developing several chronic diseases, including 
cardiovascular disease, metabolic syndrome, type 2 diabetes and several cancers (31). 
Systemic effects of physical activity include increased insulin sensitivity (32), 
decreased blood pressure (33), improvement in blood lipid profile (34) and reduction 
of chronic low-grade inflammation (35). Physical activity has gathered substantial 
attention as a potentially effective key habit, or lifestyle, for elevating cognitive 
function and improving brain health throughout the lifespan. Studies have shown a 
direct correlation between increased levels of physical activity and improved cognition, 
with increases in hippocampal volume following exercise (36). The beneficial effects 




Thus, the benefits of physical activity on cognition appear to be widespread across all 
age groups. Further, physical exercise is also associated with increased general cerebral 
blood flow and nutrition supply (38), angiogenesis (39), neural activation (40) and 
reduced age-related degeneration of brain tissue (41). Moreover, it has been 
demonstrated that physical activity can ameliorate the effect of neurological diseases 
characterized by cognitive deficits, particularly in Alzheimer’s disease, Parkinson’s 
disease, and psychiatric illnesses such as depression and schizophrenia (42). Some of 
the potential, biological mechanisms behind the positive effects of physical activity on 
cognition includes the optimizing effects on hormonal stress response systems (such as 
the hypothalamic-pituitary-adrenal axis), the anti-inflammatory action through 
microglial activation and improved trophic factor signaling with attention centering on 
the neurotrophins (43, 44). The later are comprised of a group of closely related 
polypeptides that regulate a variety of neuronal functions including proliferation, 
survival, migration and differentiation. Among these, brain-derived neurotrophic factor 
(BDNF) is regarded as perhaps the most important (44), and could be a mediating factor 
between an exercise-related transcriptional factor and adult neurogenesis, an hypothesis 
introduced in more detail in a later paragraph below. Other important signaling 
molecules with neurotrophic properties, and has been shown to be regulated by exercise 
and influence adult neurogenesis include vascular endothelial growth factor (VEGF), 
insulin like growth factor 1 (IGF-1), fibroblast growth factor 2 and nerve growth factor 
(45). 
Brain tumors in children  
 
One patient group that potentially could benefit from research unraveling the molecular 




hippocampal function is children treated with IR because of CNS tumors, sadly often 
suffering from long-term neurocognitive sequelae in aftermath. The mean annual 
incidence rate of cancer in children under 15 years is 16.0 per 100,000 in Sweden (46). 
Leukemia, CNS-tumors and Lymphomas constitute about 70% of the childhood cancer 
diagnoses. Leukemia represents approximately 30% of all these malignancies being the 
most common childhood cancer overall, where 85% of these cases consists of acute 
lymphatic leukemia. The second most common malignancy and the most common solid 
cancer in children is brain tumor, representing approximately 28% of all childhood 
cancers. The age distribution in CNS-tumors has a relatively even distribution without 
evident incidence peaks. In Sweden, the most common types of brain tumors are 
astrocytoma (originating from astrocytes, ~45%), medulloblastoma (originating from 
the neuroectodermal precursor cells, ~20%) and ependymoma (originating from 
ependymomal cells, ~10%).  
Over the past four, five decades, there has been increase in the incidence of children 
diagnosed with leukemia and brain tumors. The increase is partly due to improved 
diagnostic techniques and routines of detection. However, there has been a gradual 
improvement of the outcome for all diagnoses of childhood cancer since the 1970s. The 
combination of surgery, IR and chemotherapy was a prominent breakthrough in the 70s 
and 80s, most pronounced in acute lymphatic leukemia and Non-Hodgkin lymphomas. 
This, so called, ‘total therapy’ is also very important in efficient brain tumor treatment. 
Typical treatment standard for malignant brain tumors is surgery followed by 
postoperative radiation and chemotherapy (47). Application of this therapy strategy 
these past decades, in combination with improved diagnostic measures have led to 
approximately 80% survival rate for children suffering from cancer in Sweden. Now, 




new treatment methods to cure even more children while at the same time reducing the 
toxic long-term side effects of the treatment. Research like in this paper hopefully 
contributes with some knowledge, about the later subject, and adds clues about how we 
can make use of exercise-related mechanisms to treat, or curb neurocognitive sequelae 
due to cranial IR in the future. 
Neurocognitive deficits due to cranial irradiation 
Recent, therapeutic advancements in the pediatric treatment of CNS associated tumors 
has brought with it radical increase in survival rate, but also new concerns about the 
neurocognitive deficits seen in surviving patients many years after cranial IR , as stated 
above. These long term side effect, also called sequelae, affects as many as half of the 
children treated for brain tumors with RT. The two most common forms of sequelae is 
neuropsychological and neuroendocrinological damage. These sequelae comprise 
intellectual deterioration such as reduced attention span, memory, learning and 
information processing speed, as well as perturbed growth and puberty (48-50). There 
is evidence that even low doses of ionizing radiation can bring about these deleterious 
effects on cognition (51). These iatrogenic symptoms tend to be more severe the 
younger the children (52-54). Further, cognitive complications from brain IR appear 
not only in children but also to some degree in adults, greatly increasing the risk of 
dementia in long-term survivors (55). 
Radiation therapy detrimental for hippocampal function 
There are several mechanisms in which hippocampal function is impaired by radiation, 
but some of these negative effects can be partially restored or alleviated by exercise.  
Firstly, in the treatment of brain tumors and other forms of cancer, cranial RT induces 




of human hippocampus neurogenesis, resulting in long-term cognitive deficits (56). IR 
target tumor cells which have prominent proliferative capacity, but also affect the stem 
and progenitor cells in hippocampus, shown in studies on rodents (57, 58). Secondly, 
radiation therapy is detrimental for the neurogenic niche due to an increased 
inflammation that creates a neural environment that inhibits to neuronal plasticity (59). 
However, studies have shown that exercise reduces inflammation and that lack of 
exercise obstructs neurogenesis, maybe through reduced levels of circulating factors, 
such as growth factors and neurotrophic factors (60, 61). In mice, voluntary physical 
exercise after cranial IR enhances hippocampal neurogenesis and improves long-term 
behavior (62). Thus, as suggested in the introduction of this paragraph, exercise in the 
form of voluntary running can prevent irradiation-induced memory decline and aid 
recovery of adult hippocampus plasticity (63). The mediating mechanisms behind these 
effects from exercise are although largely unknown. However, one of the most 
important trophic factor behind brain neurogenesis, synaptic plasticity, angiogenesis, 
memory and learning are believed to BDNF, mentioned earlier. Peripheral and central 
levels of BDNF, VEGF and IGF-1 has been shown correlated with exercise (45, 64). 
For example, physical exercise can increase BDNF gene expression in hippocampus 
and there is a significant positive correlation between voluntary running distances and 
levels of BDNF mRNA (65). Lastly, IR decreases microglia in hippocampus that have 
been implicated in maintaining the neurogenic niche in (66, 67), where voluntary 
exercise has been shown to increase microglial population (68). To sum up, research 
stated above shows that RT and IR is detrimental for hippocampal function through 
different mechanisms, but promisingly, results from experimental research on rodents 
show that exercise can alleviate some of the negative effects from IR. The next 




that acts as a key mediator behind exercise-related muscle tissue adaptions and, via 
BDNF, possibly linked with hippocampal neurogenesis through a newly found 
molecular pathway.  
Transcriptional factor PGC-1a and hippocampal neurogenesis 
 
The transcription factor peroxisome proliferator-activated receptor gamma co-activator 
1-alpha (PGC-1a) is induced in skeletal muscle in short-term and endurance exercise. 
Because PGC-1a is a key mediator of the metabolic and structural adaptation of muscle 
to aerobic exercise, PGC-1a is considered to be responsible for many of the beneficial 
exercise-related effects in muscle. PGC-1a is a potent regulator of gluconeogenesis, a 
powerful inducer of mitochondrial biogenesis, angiogenesis, muscle fiber-type 
switching and protects against atrophy (69-72). PGC-1a is believed to be one of the key 
regulators of the stimulation of mitochondrial biogenesis by exercise (73), and one 
isomer of PGC-1a has been found to regulate and coordinate factors involved in skeletal 
muscle hypertrophy (73, 74).  
PGC-1a is widely expressed in the rodent brain and the level of expression is stable 
throughout different physiological states, e.g. states of caloric deficiency, obesity or 
cold exposure (75). Because PGC-1a expression in the brain is widely distributed, it 
suggests that it may have a fundamental physiologic role in the CNS. Later studies have 
shown that lack of PGC-1a in the brain is associated with neurodegeneration (76, 77). 
Further, PGC-1a might play an important role in the formation and maintenance of 
neuronal dendritic spines (78). Interestingly, long-term forced treadmill running over 
12 weeks increases mRNA expression of PGC1-a in various areas of the brain, and are 
generally similar in magnitude as those in skeletal muscle. Exercise also increases 





Exercise-induced PGC-1a increases reactive oxygen species-detoxifying enzymes, 
which might be the reason for PGC-1a protective function against oxidative stress (80), 
which suggest that PGC-1a may also have a beneficial impact on irradiation-induced 
oxidative stress (81). A recently identified PGC-1a-dependent myokine, FNDC5, is 
cleaved and secreted from muscle during exercise (82). Interestingly, elevated 
peripheral levels of FNDC5 by exercise induce expression of BDNF in hippocampus 
(83), suggesting that there is a potential link between exercise and hippocampal 
neurogenesis through a PGC-1a/FNDC5 pathway. 
A transgenic mouse model with skeletal muscle-specific upregulation of PGC1-alpha 
through the muscle creatinine kinase promoter (MCK-PGC1a) has an endurance 
exercise phenotype, and shows resistance to metabolic diseases by preventing age-
associated insulin resistance and improving muscular insulin signaling (84), as well as 
against stress-induced depression (85). This transgenic mouse model is used in this 
thesis study.  
AIM 
By understanding the cellular and molecular consequences of wheel running in the 
rodent brain, and finding molecular targets, it may be possible to develop novel 
therapeutic interventions that mimic the positive effects of exercise. These potential 
pharmaceuticals will particularly be good for those who are unable to engage in 
vigorous physical activity. The purpose of this study is thus to find means to improve 
recovery and protect from neurological conditions such as irradiation-injury to the 
brain, stroke and age-related cognitive decline. The two main objectives in this study 




1) Determine if forced expression of PGC-1a in muscle results in affected baseline or 
exercise-induced levels of hippocampal neurogenesis 
2) Determine if forced expression of PGC-1a in muscle ameliorates irradiation-reduced 
levels of proliferation in SGZ 
 
MATERIAL AND METHODS 
Animals   
Transgenic MCK-PGC-1a  animals on C57BL/6J background (The Jackson Lab- 
oratory; Stock no. 008231), a kind gift from Dr. Bruce Spiegelman (Harvard Medical 
School, Boston, MA), have been previously described (65). Female C57BL/6J (Charles 
River, Germany) mice were used for breeding purposes. Animals were housed at a 
constant temperature (24°C) with 50-60% relative humidity. A 12-h light/dark cycle 
was maintained with lights from 07:00 to 19:00 with ad libitum access to food and 
water. All the experiments were approved by the Gothenburg ethical committee on 
animal research (#317- 2012).  
 
Voluntary Exercise  
At 2 months of age female mice were single housed in cages with free access to running 
wheels. After 5 days of acclimatization, running wheels were unlocked and monitored 
for activity, or as a control environment kept locked for the sedentary group. For 3 
consecutive days following unlocking, animals were given daily intraperitoneal 
injections with 50 mg/kg BrdU (Roche Diagnostics)  
 
Irradiation Procedure  
At 4 months of age male animals were anesthetized with an intraperitoneal injection of 




The head was covered with a 1 cm tissue-equivalent material to ensure an even IR dose 
into the underlying tissue. Whole brain IR was administered as a single dose of 4 Gy 
using a linear accelerator (Varian Clinac 600 CD, Radiation Oncology Systems LLC) 
with 4 MV nominal photon energy and a dose rate of 2.3 Gy/min. The sham-irradiated 
control mice were anesthetized but not subjected to IR. After IR the animals were 
returned to their cages. Animals were given daily intraperitoneal injections with 50 
mg/kg BrdU (Roche Diagnostics) from day 3 to 8 post IR.  
 
Sample Processing  
Four weeks following unlocking of running wheels or IR mice were deeply anesthetized 
with a peritoneal injection of 50 mg/kg sodium thiopenthal (Pentothal, Sigma-Aldrich) 
and transcardially perfused with cold saline solution (0.9% NaCl) followed by 4% 
paraformaldehyde (PFA) in phosphate-buffered solution (PBS). The brains were 
immersion-fixed in PFA and subsequently cryoprotected in 30% sucrose in 0.1 M PBS 
after 24h. Left hemispheres were sectioned sagitally (25 mm thickness), and collected 
in series of 12 for immunohistochemistry using a sliding microtome (SM2000R, Leica 
Microsystems) modified for frozen sectioning. Sections were stored at 4°C in 
cryoprotectant solution (TCS) containing 25% glycerol and 25% ethylene glycol in 0.1 
M PBS.  
 
Immunohistochemistry  
Staining with BrdU and NeuN 
Free-floating immunohistochemistry sections were rinsed in Tris-buffered saline 
(TBS). An antigen retrieval step in 10mM sodium citrate (pH 6) for 20 minutes at 80°C 




antigen NeuN. For BrdU stainings, sections were incubated in 2M HCl for 30 minutes 
at 37°C and neutralized in 0.1 M borate buffer (pH 8.5) for 10 minutes at room 
temperature. For all immunostainings for, sections were incubated in blocking solution 
containing 0.1% Triton X-100, 3% donkey serum (Jackson ImmunoResearch 
Laboratories) in TBS for 30 minutes at room temperature. Primary antibodies were 
diluted in blocking solution and incubated at 4°C overnight in both rat anti-BrdU 
(1:250, AbDSerotec, OBT0030) and mouse anti-NeuN (1:5000, Millipore, MAB377). 
After rinsing in TBS, sections were incubated at room temperature with secondary 
antibody in blocking solution as follows: donkey anti-mouse 555 IgG (1:1000, 
Molecular Probes, A21202) for NeuN and donkey anti-rat 488 IgG (1:1000, Molecular 
Probes, A21208) for BrdU. For immunofluorescence TO-PRO-3 (1:1000, Molecular 
Probes, T3605) was used as nuclear stain. Sections for immunofluorescence were 
rinsed and mounted from 0.1 M PBS onto glass slides, using ProLong Gold with DAPI 
(Molecular Probes) for coverslipping. Two core dyes were used for practical reasons 
for detection compatibility with available wide field and confocal microscopy; we 
could only visualize DAPI in stereology and we could only visualize TO-PRO-3 in the 
confocal microscope.  
Staining with Ki67 
For Ki67 stainings, sections were incubated in 0,01M NaCi (pH 6.0) for 20 minutes in 
80°C water bath (10 minutes to cool off). After rinsing in TBS, sections were incubated 
in blocking solution containing 0,6% H2O2 for 30 minutes and subsequently, after 
another rinsing in TBS, incubated in blocking solution containing 0.1% Triton X-100, 
3% donkey serum (Jackson ImmunoResearch Laboratories) in TBS for 30 minutes at 




(1:500) in blocking solution (0,1% TX100/3% donkey serum/TBS, as above) at 4°C 
overnight. After rinsing in TBS, sections were incubated at room temperature with 
secondary antibody, donkey-anti rabbit-BT (1:1000, 711-065-152 Jackson 
ImmunoResearch), in blocking solution (as above) for 2 hours in room temperature. 
After rinsing with TBS, sections were treated with Avidin-Biotin-Peroxidase for 1 hour. 
Then sections were treated with a 3,3’-diaminobenzidine (DAB) solution (per 1 ml 
TBS; 10 μl DAB 25 mg/ml, 0,3 μl H2O2 30%, 5 μl of 8% NiCl2) for 5-10 minutes. 
Finally, the sections were washed in tap water and TBS, and mounted from 0.1 M PBS 
on glass slides using X-TRA-kitt® (Medite) for coverslipping.  
 
Imaging and Quantification  
Investigator blinded stereological quantification was performed using a Leica 
DM6000B microscope and software (StereoInvestigator v10.40, MBF Bioscience). 
Ki67-positive cells were quantified at 40x optical magnification within the different 
subregions of the dentate gyrus. The SGZ was outlined as three cell layers into the 
GCL and three cell layers into the hilus. For analysis of NeuN/BrdU co-labeling a 
Leica SP2 confocal microscope was used. Co-localization was determined at 20x 
optical magnification and 2.5x digital zoom using sequential scanning mode.  
 
Statistical Analysis  
Data was processed in Microsoft Excel 2010 (Microsoft Corp.) and IBM SPSS v22 
(IBM Corp.). For stereological analysis, data from lost or damaged sections were 
estimated as the average value of the two anatomically adjacent sections. Statistical 
analysis was performed using a statistical software (GraphPad Prism 6, GraphPad 




of variance. For multiple comparisons one-way analysis of variance (ANOVA) was 
used in conjunction with Tukey’s post-hoc test. For repeated measures comparisons 
two-way ANOVA was used (RMANOVA). 
RESULTS  
 
Baseline and Exercise-Induced Levels of Neurogenesis under 
PGC-1a  Overexpression in Skeletal Muscle 
 
In order to investigate the baseline and exercise-induced neurogenesis in the MCK-
PGC1a animals, we housed animals individually for 4 weeks with free access to running 
wheels. Daily running distances ranged from approximately 5-8 km per day, with 
tendency towards slightly less running activity in the MCK-PGC1a mice (Two-way 
ANOVA; n.s, n=7, Fig 4B). Net neurogenesis was calculated by the ratio of NeuN-
labeled BrdU+ cells multiplied by BrdU+ cells in the GCL. Analysis with Two-way 
ANOVA showed a significant increase of net neurogenesis induced by voluntary 
running for both animal groups (***, p<0,001; n=4-9, Fig. 4A), by approximately 2000 
respectively 1750 cells for wild type and MCK-PGC1a mice. However, no difference 
was observed between in baseline or exercise-induced levels of neurogenesis between 





Figure 4: Characterization of Baseline and Exercise-Induced Levels of 
Neurogenesis under PGC-1a Overexpression in Skeletal Muscle.  
A) Number of newborn neurons calculated as ratio of NeuN+/BrdU+cells in the GCL 
4 weeks after unlocked running wheels, expressed as mean ± SEM for sham and 
irradiated animals. Significant increase after voluntary exercise in both WT and 
MCK-PGC1a animals (Two-way ANOVA; ****; p<0.0001); n=4-9), but no 
significant difference between groups (Turkey’s multiple comparisons test; n.s.). B) 
Daily running distance per weeks of running (Two-way ANOVA; n.s., n=7). 
 
Effects of Muscle PGC-1a  Overexpression on Irradiation- 
Induced Inhibition of Neurogenesis 
Using a model of cranial IR, we investigated the potential protective or regenerative 
effects from chronic muscular overexpression of PGC-1a on neurogenesis after IR. Net 
neurogenesis was calculated by the ratio of NeuN-labeled BrdU+ cells multiplied by 
BrdU+ cells in the GCL, with a significant decline in the relative number of new 
neurons to other cell types after radiation therapy in both groups (Two-way ANOVA; 
*, p<0,05, n=7-8, Fig. 5A). To analyze the neuronal lineage, DCX immunoreactivity 
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was used as marker for immature neuron (work done by another student in the research 
group), 4 weeks after radiation treatment, a significant decline in the number of DCX 
positive cells was observed in the GCL in both groups (Two-way ANOVA; *, p<0,05, 
Fig. 5B). The number of newborn cells in the neurogenic regions of the DG, SGZ and 
GCL in both groups showed a significant decline after IR (Two-way ANOVA; *, 
p<0,05, Fig. 5C). Total numbers of newborn, Ki67 positive cells in the GCL was not 
statistically significant before or after IR between the groups (Two-way ANOVA, n.s.; 
n=7-8, Fig. 5D).  
Figure 5: Effects of Muscle PGC-1a Overexpression on Irradiation-Induced 
Inhibition of Neurogenesis. A) Number of newborn neurons calculated as ratio of 
NeuN+/BrdU+cells in the GCL 4 weeks after IR, expressed as mean ± SEM for sham 
and irradiatied animals. Significant reduction after IR in both the WT and MCK-
PGC1a animals (Two-way ANOVA; *, p<0,05; n=7-8). B) Total DCX+ cells in the 
GCL 4 weeks after IR (work done by another student in the research group). 
Significant reduction after IR in both the WT and MCK-PGC1a animals (Two-way 
ANOVA; *, p<0,05). C) Number of newborn cells in the SGZ and GCL 4 weeks after 
IR. Significant reduction after IR in both WT and MCK-PGC1a animals (Two-way 
ANOVA; *, p<0,05). D) Number of cells in cell cycle in the GCL 4 weeks after IR 







The objective of this study was to use a transgenic mouse model to observe the 
contribution of PGC1-a in exercise-induced recovery of neurogenesis following brain 
IR. Muscular overexpression of PGC-1a did not change baseline or exercise-induced 
levels of neurogenesis and did not ameliorate the negative effects on neurogenesis after 
IR in mice, thereby suggesting that PGC-1a overexpression in muscle is not sufficient 
to phenocopy the exercise-induced effects on neurogenesis that have previously been 
described.  
Some earlier studies have reported upregulation of neurotrophic factors in these 
transgenic animals (82, 83), therefore we hypothesized that a constitutive PGC-1a 
overexpression could result in increased levels of baseline neurogenesis, with possible 
additive effect on exercise-induced neurogenesis. However, we did not detect any effect 
of chronic muscular overexpression of PGC-1a on physiological levels of baseline and 
exercise-induced neurogenesis in a running-wheel paradigm (Fig. 4). Other studies 
have reported that the MCK-PGC1a animals have unchanged baseline levels of gene 
expression for a number of neurotrophic factors in the hippocampus, including BDNF 
(85, 86). This,  together with our findings, suggest that the FNDC5/BDNF pathway 
might not play a major role in exercise-mediated induction of hippocampal 
neurogenesis.  
Although this study did not detect differences at baseline between PGC-1a mice and 
controls, we hypothesized that a different effect could emerge in a pathophysiological 
model where exercise has beneficial effects, in this case after IR to the brain. We 




both MCK-PGC1a and wild type mice (Fig 5C), which disaffirm our hypothesis that 
muscular overexpression of PGC-1a could protect hippocampal cytogenesis from IR 
damage. The reduction of immature neurons (DCX) after radiation therapy was 
statistically significant in both (Fig. 5B), which could indicate that there is no difference 
between animals regarding survival rate of immature neurons or maturation rate after 
IR. We did observe a significant difference in the number of newborn mature neurons 
between the groups (Fig. 5A), indicating that the net neurogenesis in both animals is 
negatively affected following brain IR as was to be expected from previous studies (87). 
However, we did not observe any difference in number of cells in cell cycle 4 weeks 
after IR between the groups (Fig. 5D), suggesting that the dosage of IR used was not 
sufficient to elicit significant difference in rate of proliferation after treatment with IR. 
Differences in dosage of IR could affect the level of effect on neurogenesis; using a 
lower or higher IR dose, as well as older or younger animals at the point of IR could 
lead to different results. However, the IR dose used was chosen based on the expected 
age-dependent decline of neurogenesis at 4 months of age in mice (88). In some species, 
for example rats and voles, there are sex differences in hippocampal neurogenesis. In 
laboratory mice however, research is equivocal as some studies have found higher cell 
proliferation and survival in female mice, while other studies have shown no such 
differences between male and female mice (89). In the running experiment we only 
used female mice. Because of the aforementioned equivocal results concerning sex 
difference on hippocampal neurogenesis in mice, we cannot draw certain conclusions 
on baseline and exercise-induced levels of neurogenesis in MCK-PGC1a mice based 
only on this data. However, in the larger PhD project, the running experiment includes 
both sexes and animals of different ages, and data from those experiments allows for 




we only used male animals. It would be better to include female animals also. However, 
the decision to only include male animals was merely a matter of practicality, an issue 
of breeding and housing the animals, and not of methodological choice.  
Here, we use a transgenic murine model with chronic upregulation of PGC-1a in 
skeletal muscle. Acute overexpression of FNDC5, a PGC-1a-inducible protein, resulted 
in increased BDNF expression in the hippocampus (83), at the same time Agudelo et. 
al did not see a difference in hippocampal BDNF gene expression in the chronic muscle 
activation model (85). In our study, the MCK-PGC1a mice showed a trend towards 
slightly less elevated levels of neurogenesis after exercise in comparison to wild type 
(n.s.; Fig. 4A). Since the transcriptional factor has been expressed constitutively during 
the development phase, this could have led to compensatory adaptations of molecular 
pathways. Hence, chronic expression of PGC-1a, seen as an adaptive response to long-
term regular physical exercise, might not have the same effects on hippocampal 
neurogenesis as an acute expression of the same factor. It needs to be clarified if MCK-
PGC-1a mice can upregulate downstream signaling factors released into the blood 
stream in the same physiologically relevant levels as exercise, and what other pathways 
in muscle also could be important for mediating exercise-inducing changes in the brain. 
Lastly, it also remains unclear if exercise-induced signaling from muscle alone is 
sufficient to produce changes in hippocampal neurogenesis. 
The research on PGC-1a and its related molecular pathways, and downstream targets, 
adds to our understanding of exercise-related benefits on the brain. Further studies are 
needed to investigate the actions of PGC-1a and other molecular mechanisms by 
which muscle and other tissue could mediate exercise-induced effects after IR. 
Hopefully, this could lead to the creation of new drugs that can ameliorate irradiation-





Before any conclusions can be drawn, the study should be repeated. However, this study 
found no effects of muscular PGC-1a overexpression for baseline and exercise-induced 
neurogenesis, or on irradiation-reduced proliferation in SGZ. This suggest that PGC-1a 
overexpression might not be sufficient to phenocopy the exercise-induced effects on 
neurogenesis. As for future studies, using an acute model of PGC-1a expression, that 
mimics the acute physiological adaptions by exercise, could perhaps elucidate if PGC-
1a plays a role in mediating the exercise-induced neurogenesis.  
 
POPULÄRVETENSKAPLIG SAMMANFATTNING 
Molekylära mekanismer bakom träningens positiva effekter på 
hjärnans återhämtning efter strålning 
 
Introduktion 
Hjärntumörer utgör cirka en tredjedel av alla årliga fall av barncancer i Sverige. 
Strålningsbehandling är en mycket viktig hörnsten i den aggressiva behandlingen av 
dessa tumörer, men detta medför också skador på friska delar av hjärnan. Strålning 
förgör i första hand ”nyfödda” celler i hjärnan vilket kraftigt minskar nybildningen av 
hjärnceller, s.k. neurogenes. Vi tror att neurogenes är viktigt för normal hjärnfunktion 
och att strålningens negativa effekt på den för övrigt friska hjärnan, åtminstone delvis, 
kan förklara varför unga patienter nästan uteslutande upplever livslång fortskridande 
försämring av kognitiva funktioner, t ex minnet. En möjlighet är att använda sig av 
behandlingsstrategier för att stimulera hjärnans egna möjligheter till läkning genom 




exempelvis löpning, och en ökad neurogenes. Tidigare studier gjorda på gnagare har 
visat att fysisk aktivitet delvis kan återställa nivåerna av nybildning av hjärnceller efter 
strålning. Det är dock i stort sett okänt hur fysisk aktivitet stimulerar neurogenes. En 
studie har visat en möjlig koppling mellan fysisk aktivitet och neurogenes via ett 
äggviteämne kallat PGC1-alfa. I denna studie har vi använt möss som via 
genmodifiering producerar onaturligt mycket av detta äggviteämne för att studera om 
det kan skydda hjärnan från skada av strålning. 
 
Syfte 
Syftet är att undersöka om en överproduktion av äggviteämnet PGC-1-alfa som är 
kopplat till fysisk aktivitet kan öka nybildningen av hjärnceller och därmed öka 
hjärnans återhämtningsförmåga efter skadande strålning i samband med behandling 
mot hjärntumörer. Genom att undersöka och förstå de bakomliggande mekanismerna 
som orsaker träningens positiva effekter på hjärnans återhämtning efter skada, kanske 
man i framtiden kan skapa läkemedel som kan hjälpa patienter.  
 
Metod 
För strålningsexperimentet sövde man både genmodifierade möss med onaturligt 
mycket av äggviteämnet PGC1-alfa för att sedan stråla de över huvudet. Som 
kontrolldjur sövdes normala möss också, men de utsattes aldrig för strålning. För 
springexperimentet, lät man genmodifierande möss och kontrollmöss hållas med och 
utan tillgång till springhjul. I båda experimenten genomfördes dagliga injektioner av en 
celldelningsmarkör i mössens bukhåla, i antingen 3 eller 5 dagar under experimentens 
första vecka. Efter 4 veckor avlivades djuren och hjärnorna fixerades i formalinlösning 




en kvantifiering och karaktärisering av nybildningen av hjärnceller med hjälp av olika 
cellmarkörer och mikroskop som tillåter väldigt hög upplösning för räkning. 
 
Resultat 
I springexperimentet såg man att mössen som tilläts springa i springhjul hade en 
statistiskt säkerställd högre nivå av nybildning av hjärnceller, jämfört med de möss som 
inte fick springa. Däremot fann man ingen skillnad mellan de genmodifierade mössen 
med en överproduktion av äggviteämnet PGC-1-alfa i jämförelse med normala möss. I 
strålningsexperimentet såg man ingen skillnad i totala antalet nybildade hjärnceller, 




Överproduktion av äggviteämnet PGC-1-alfa som är kopplat till fysisk aktivitet hos 
möss påverkade inte nybildning av hjärnceller, sk neurogenes. Överproduktion av 
äggviteämnet PGC-1-alfa skyddade inte heller nybildningen av hjärnceller från den 
skadliga effekten från strålning. Denna studien kunde inte visa att springande, 
genmodifierade möss med onaturligt hög produktion av äggviteämnet PGC-1-alfa hade 
mer nybildning av hjärnceller jämfört med normala springande möss, eller att 
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Figure 1: The hippocampus is located within the medial temporal lobe of the 
human brain hemispheres (7) 
 
Figure 2: Anatomical description of the different hippocampal layers in mice. The 
pyramidal layer (PL) is divided into three subareas (CA1‐3). The stratum lucidum 
(SL) is a separate area alongside the PL. The SGZ is outlined by the border between 
the GCL and hilus. Colors outline the areas: GCL (blue), molecular cell layer (MCL, 
magenta), Hilus (green), PL (white), CA1 (red), CA2 (orange), CA3 (yellow) and SL 






Figure 3: Overview of the adult neurogenesis in hippocampus. 
Radial glia-like stem cell (green) divides and immature progenitor cells (yellow) start 
their differentiation towards becoming neurons. The cell maturation continues by 
exiting the cell cycle and the cells (red) start to stretch out their dendritic trees 
towards the molecular cell layer (MCL) to establish functional synaptic connections. 
The increasing synaptic input to the cells (violet) drives the maturation process to its 
final phases where the cell is considered a mature neuron. 
 
Figure 4: Characterization of Baseline and Exercise-Induced Levels of 
Neurogenesis under PGC-1a Overexpression in Skeletal Muscle.  
A) Number of newborn neurons calculated as ratio of NeuN+/BrdU+cells in the GCL 
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4 weeks after unlocked running wheels, expressed as mean ± SEM for sham and 
irradiated animals. Significant increase after voluntary exercise in both WT and 
MCK-PGC1a animals (Two-way ANOVA; ****; p<0.0001); n=4-9), but no 
significant difference between groups (Turkey’s multiple comparisons test; n.s.). B) 
Daily running distance per weeks of running (Two-way ANOVA; n.s., n=7). 
 
Figure 5: Effects of Muscle PGC-1a Overexpression on Irradiation-Induced 
Inhibition of Neurogenesis. A) Number of newborn neurons calculated as ratio of 
NeuN+/BrdU+cells in the GCL 4 weeks after IR, expressed as mean ± SEM for sham 
and irradiatied animals. Significant reduction after IR in both the WT and MCK-
PGC1a animals (Two-way ANOVA; *, p<0,05; n=7-8). B) Total DCX+ cells in the 
GCL 4 weeks after IR (work done by another student in the research group). 
Significant reduction after IR in both the WT and MCK-PGC1a animals (Two-way 
ANOVA; *, p<0,05). C) Number of newborn cells in the SGZ and GCL 4 weeks after 
IR. Significant reduction after IR in both WT and MCK-PGC1a animals (Two-way 
ANOVA; *, p<0,05). D) Number of cells in cell cycle in the GCL 4 weeks after IR 
(Two-way ANOVA; n.s; n=7-8). 
 
